|
|
|||||||
Lymphoproliferative Disorders |
1 INSERM, E0210, Hôpital Necker, Paris
2 Service dHematologie Biologique, Groupe Hospitalier Pitie-Salpetriere, Paris
3 Laboratoire dHématologie, CHU Purpan, Toulouse
4 Université Pierre et Marie Curie, Paris VI
5 Université Rene Descartes, Paris V, France
Correspondence: Florence Nguyen-Khac, Service dHematologie Biologique Groupe Hospitalier Pitié-Salpetriére, Pavillon Laveran, 47-83 Bd de lHopital, 75013 Paris, France. E-mail:florence.nguyen{at}psl.aphp.fr.
Homeobox containing transcription factors are frequently deregulated in human hematologic malignant diseases either indirectly through an abnormality of an upstream factor, or directly through rearrangement of the gene itself. Study of T-cell acute lymphoblastic leukemia identified the related non-clustered homeobox transcription factors, TLX1 and TLX3, as frequently ectopically expressed as a result of chromosomal translocations. We report the deregulation of a non-clustered homeobox gene in a new type of t(5;14)(q35;q11) translocation in a mature peripheral B-cell leukemia. This translocation results in the ectopic expression of the CSX1/NKX2-5 gene on chromosome 5q35 due to its juxtaposition to the TCR
gene on chromosome 14q11. Expression of the CSX1/NKX2-5 protein conferred enhanced replating potential to transduced murine bone marrow cells. Our study establishes that deregulation of homeobox encoding genes is not restricted to acute leukemic proliferations, but is also observed in chronic malignant diseases.
Key words: chromosomal translocation, homeobox, transcriptional activation, chronic lymphocytic leukemia.
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |